{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE314nnn/GSE314036/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314036"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Oncolytic vaccinia virus JX-594 demonstrates subtype-specific efficacy and predictive biomarkers in gastric cancer cell lines","description":"This project investigates the therapeutic potential of the oncolytic vaccinia virus JX-594 in gastric cancer. We analyzed 49 molecularly characterized GC cell lines and xenograft models, and performed transcriptomic profiling to identify subtype-specific responsiveness and explore predictive biomarkers that may guide clinical application.","dates":{"publication":"2026/04/26"},"accession":"GSE314036","cross_references":{"GSM":["GSM9380430","GSM9380397","GSM9380398","GSM9380431","GSM9380395","GSM9380396","GSM9380394","GSM9380429","GSM9380427","GSM9380428","GSM9380425","GSM9380426","GSM9380423","GSM9380424","GSM9380421","GSM9380422","GSM9380420","GSM9380418","GSM9380419","GSM9380416","GSM9380417","GSM9380414","GSM9380415","GSM9380412","GSM9380413","GSM9380410","GSM9380411","GSM9380409","GSM9380407","GSM9380408","GSM9380405","GSM9380406","GSM9380403","GSM9380404","GSM9380401","GSM9380402","GSM9380400","GSM9380441","GSM9380442","GSM9380440","GSM9380438","GSM9380439","GSM9380436","GSM9380437","GSM9380434","GSM9380435","GSM9380432","GSM9380399","GSM9380433"],"GPL":["16791"],"GSE":["314036"],"taxon":["Homo sapiens"]}}